1. Home
  2. CFND vs VRCA Comparison

CFND vs VRCA Comparison

Compare CFND & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CFND

C1 Fund Inc.

N/A

Current Price

$4.98

Market Cap

36.5M

Sector

N/A

ML Signal

N/A

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

HOLD

Current Price

$8.77

Market Cap

32.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CFND
VRCA
Founded
N/A
2013
Country
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.5M
32.7M
IPO Year
2025
2018

Fundamental Metrics

Financial Performance
Metric
CFND
VRCA
Price
$4.98
$8.77
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
N/A
402.7K
Earning Date
N/A
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$30,829,000.00
Revenue This Year
N/A
$373.65
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
234.73
52 Week Low
N/A
$3.28
52 Week High
N/A
$9.82

Technical Indicators

Market Signals
Indicator
CFND
VRCA
Relative Strength Index (RSI) N/A 65.02
Support Level N/A $7.06
Resistance Level N/A $9.78
Average True Range (ATR) 0.00 1.29
MACD 0.00 0.02
Stochastic Oscillator 0.00 71.74

Price Performance

Historical Comparison
CFND
VRCA

About CFND C1 Fund Inc.

C1 Fund Inc is a non-diversified, closed-end management investment company designed to give investors access to the private digital asset ecosystem. Its investment objective is to maximize its portfolio's total return. The fund targets a handpicked portfolio of the late-stage private companies driving the future of digital asset services and technology. It offers early access to the next generation of category-defining companies and aims to bridge the gap between public and private markets and give investors access to the private companies with the safeguards of a NYSE listed fund that is regulated and liquid.

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.

Share on Social Networks: